SAR-20347

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSAR-20347
Drug Alias NameSAR-20347
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2Tyrosine-protein kinase JAK1
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSareum
China Registration ClassN/A

Develop Information

Active CompaniesSareum
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A